2005
DOI: 10.1007/s00264-005-0673-3
|View full text |Cite
|
Sign up to set email alerts
|

Sarcomatous change in the Pagetoid tibiae

Abstract: We reviewed 13 cases of tibial Paget's sarcoma constituting 14% of all registered Paget's sarcoma cases of the Scottish Bone Tumour Registry between January 1947 and June 2004. Eleven patients were male, and in ten patients the tumour involved the upper half of the tibia. In all cases, the main presenting feature was progressively worsening pain followed by a mass in six, a pathological fracture in five and tibial bowing in four. In nine patients, a lytic lesion was seen radiologically. Histologically, there w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2006
2006
2014
2014

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 11 publications
0
2
0
Order By: Relevance
“…Bisphosphonates are often effective at helping bone pain but it is uncertain at present if they alter the natural history of Paget's or prevent complications. The prognosis is poor for patients who develop osteosarcoma, even with agressive treatment (Sharma et al, 2005).…”
Section: Prognosismentioning
confidence: 99%
“…Bisphosphonates are often effective at helping bone pain but it is uncertain at present if they alter the natural history of Paget's or prevent complications. The prognosis is poor for patients who develop osteosarcoma, even with agressive treatment (Sharma et al, 2005).…”
Section: Prognosismentioning
confidence: 99%
“…Bisphosphonate treatment is frequently given before elective orthopedic surgery to try to reduce operative blood loss, but the effects of bisphosphonate therapy on blood loss have never been studied in a controlled trial. Orthopedic surgery might also be needed in patients who develop osteosarcoma, but the prognosis is poor even with aggressive operative treatment, with an overall 5-year survival of about 6% 112115…”
Section: Treatment Options For Pdbmentioning
confidence: 99%